We are pleased to present this special supplementofDrugDevelopmentResearch, focusing on the useof biological therapy in the therapeutic areas ofrheumatology and dermatology. The supplement hasbeen written by members of the faculty of a Seminarheld on September 20–21, 2013 in Avigliano Umbroand facilitated by an unrestricted grant from PfizerItalia. The contributors are all rheumatologists and der-matologists with substantial experience in the treatmentof chronic inflammatory rheumatic and dermatologicalconditions such as rheumatoid arthritis (RA), psoriasis,psoriatic arthritis (PsA), and spondyloarthropathies(SpA) such as ankylosing spondylitis (AS).
Seminars in Research 2013
Gisondi, Paolo;
2014-01-01
Abstract
We are pleased to present this special supplementofDrugDevelopmentResearch, focusing on the useof biological therapy in the therapeutic areas ofrheumatology and dermatology. The supplement hasbeen written by members of the faculty of a Seminarheld on September 20–21, 2013 in Avigliano Umbroand facilitated by an unrestricted grant from PfizerItalia. The contributors are all rheumatologists and der-matologists with substantial experience in the treatmentof chronic inflammatory rheumatic and dermatologicalconditions such as rheumatoid arthritis (RA), psoriasis,psoriatic arthritis (PsA), and spondyloarthropathies(SpA) such as ankylosing spondylitis (AS).File | Dimensione | Formato | |
---|---|---|---|
Drug Development Research - 2014 - Gisondi - Seminars in Research 2013.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
36.95 kB
Formato
Adobe PDF
|
36.95 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.